Association between interleukin-32 gene polymorphism and susceptibility to preeclampsia

References

• Harmon AC, Cornelius DC, LM A, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci. 2016;130(6):409–419.
   PubMed Web of Science ®Google Scholar
• Staff AC, Benton SJ, von Dadelszen P, et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 2013;61(5):932–942. .
   PubMed Web of Science ®Google Scholar
• Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017 Sep;39(9):496–512.
   PubMedGoogle Scholar
• HEJ Y, Murthi P, Brennecke SP, et al. Genetic approaches in preeclampsia. Methods Mol Biol. 2018;1710:53–72.
   PubMedGoogle Scholar
• Saito S, Shiozaki A, Nakashima A, et al. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;8(2):192–209.
   Google Scholar
• Sowmya S, Sri MK, Ramaiah A, et al. Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia. Clin Exp Immunol. 2014;178(2):334–341.
   PubMed Web of Science ®Google Scholar
• Salimi S, Mohammadoo-Khorasani M, Yaghmaei M, et al. Possible association of IL-4 VNTR polymorphism with susceptibility to preeclampsia. Biomed Res Int. 2014;2014:497031.
   PubMed Web of Science ®Google Scholar
• Chen P, Gong Y, Pu Y, et al. Association between polymorphisms in IL-27 gene and pre-eclampsia. Placenta. 2016;37:61–64.
   PubMed Web of Science ®Google Scholar
• Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol. 2017;17(1):49–59.
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003;59(2):161–173.
   PubMed Web of Science ®Google Scholar
• MI V-R, Solleiro-Villavicencio H, Soto-Vega E. Th1, Th2, Th17 and Treg levels in umbilical cord blood in preeclampsia. J Matern Fetal Neonatal Med. 2016;29(10):1642–1645.
   PubMed Web of Science ®Google Scholar
• Panelli MC, Wang E, Phan G, et al. Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol. 2002;3(7):research0035.1. . RESEARCH0035
   PubMed Web of Science ®Google Scholar
• Dahl CA, Schall RP, HL H, et al. Identification of a novel gene expressed in activated natural killer cells and T cells. J.Immunol. 1992;148(2):597–603.
   PubMed Web of Science ®Google Scholar
• Kim SH, SY H, Azam T, et al. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22(1):131–142.
   PubMed Web of Science ®Google Scholar
• Al-Shobaili HA, Rasheed Z. Elevated gene expression of Interleukin-32 isoforms alpha, beta, gamma, and delta in the peripheral blood of chronic psoriatic patients. Diseases. 2018;6(1):21.
   PubMedGoogle Scholar
• Arcaroli JJ, Liu N, Yi N, et al. Association between IL-32 genotypes and outcome in infection-associated acute lung injury. Crit Care. 2011;15(3):R138.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou B, Zhao Y, et al. Association of plasma IL-32 levels and gene polymorphisms with systemic lupus erythematosus in Chinese Han population. Dis Markers. 2016;2016:2460206.
   PubMed Web of Science ®Google Scholar
• Nold-petry CA, Rudloff I, Baumer Y, et al. IL-32 promotes angiogenesis. J Immunol. 2014;192(2):589–602. .
   PubMed Web of Science ®Google Scholar
• Sloot YJE, Smit JW, Joosten LAB, et al. Insights into the role of IL-32 in cancer. Seminars in Immunology 2018;38:24–32.
   Google Scholar
• Practice Bulletin No ACOG. 202. gestational hypertension and pre-eclampsia. Obstet Gynecol. 2019;133(1):e1–e25.
   Web of Science ®Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, TM I. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63(6):601–610.
   PubMed Web of Science ®Google Scholar
• Hong JT, Son DJ, CK L, et al. Interleukin 32, inflammation and cancer. Pharmacol Ther. 2017;174:127–137.
   PubMed Web of Science ®Google Scholar
• Damen M, Schraa K, Tweehuysen L, et al. Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients. Sci Rep. 2018;8(1):14050.
   PubMedGoogle Scholar
• Kim SH, Han SY, Azam T, et al. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22:131–142.
   PubMed Web of Science ®Google Scholar
• Damen MS, Agca R, Holewijn S, et al. IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis. Sci Rep. 2017;7(1):41629. .
   PubMedGoogle Scholar
• Hesampour F, Namavar JB, Tahmasebi F, et al. Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome. Iran J Allergy Asthma Immunol. 2019;18(1):91–99.
   PubMed Web of Science ®Google Scholar
• Shamoun L, Kolodziej B, Andersson RE, et al. Protein expression and genetic variation of IL32 and association with colorectal cancer in Swedish patients. Anticancer Res. 2018;38(1):321–328.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhong M, Yu YH. Association between interleukin-4 polymorphisms and risk of pre-eclampsia in a population of Chinese pregnant women. Genet Mol Res. 2017;16(2):2.
   Web of Science ®Google Scholar
• Kang L, CH C-H, Yu C-H, et al. An association study of interleukin-4 gene and preeclampsia in Taiwan. Taiwan J Obstet Gynecol. 2014;53(2):215–219.
   PubMed Web of Science ®Google Scholar
• Song L, Zhong M. Association between Interleukin-10 gene polymorphisms and risk of early-onset preeclampsia. Int J Clin Exp Pathol. 2015;8(9):11659–11664.
   PubMed Web of Science ®Google Scholar
• Wang H, Guo M, Liu F, et al. Role of IL-17 variants in preeclampsia in Chinese Han women. PLoS One. 2015;10(10):e0140118. .
   PubMed Web of Science ®Google Scholar
• Niu Z, Zhao X, Liu H, et al. Impact of IL-22 and IL-22 receptor alpha 1 polymorphisms on preeclampsia risk in Chinese Han women. J Cell Biochem. 2018;119(6):4656–4663. .
   PubMed Web of Science ®Google Scholar
• Zhang M, WD X, Zhu Y, et al. Serum levels of cytokines in systemic lupus erythematosus: association study in a Chinese population. Z Rheumatol. 2014;73(3):277–280.
   PubMed Web of Science ®Google Scholar
• YJ H, JS P, Kang MI, et al. Increased serum interleukin-32 levels in patients with Behçet’s disease. Int J Rheum Dis. 2018;21(12):2167–2174.
   PubMed Web of Science ®Google Scholar
• Erturk K, Tastekin D, Serilmez M, et al. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer. Tumour Biol. 2016;37(1):405–412.
   PubMedGoogle Scholar